High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study

Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts. Ursodeoxycholic acid (UDCA) is the only FDA approved first-line therapy for PBC, but up to 40% of patients with PBC have an incomplete response t...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Huiling Zhu, Mengyao Zheng, Haiyu He, Hongtao Lei, Wenlin Tai, Jinhui Yang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-11-01
Edice:	BMC Gastroenterology
Témata:	Primary biliary cholangitis Neutrophil-to-lymphocyte Prognosis
On-line přístup:	https://doi.org/10.1186/s12876-023-03031-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!